PL4048229T3 - Kompozycja farmaceutyczna do zastosowania w leczeniu zapalenia pęcherza moczowego o różnej etiologii - Google Patents
Kompozycja farmaceutyczna do zastosowania w leczeniu zapalenia pęcherza moczowego o różnej etiologiiInfo
- Publication number
- PL4048229T3 PL4048229T3 PL20801016.5T PL20801016T PL4048229T3 PL 4048229 T3 PL4048229 T3 PL 4048229T3 PL 20801016 T PL20801016 T PL 20801016T PL 4048229 T3 PL4048229 T3 PL 4048229T3
- Authority
- PL
- Poland
- Prior art keywords
- cystitis
- treatment
- pharmaceutical composition
- various etiologies
- etiologies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000019762A IT201900019762A1 (it) | 2019-10-24 | 2019-10-24 | Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia |
| PCT/IB2020/059922 WO2021079303A1 (en) | 2019-10-24 | 2020-10-22 | Pharmaceutical composition for use in the treatment of cystitis of various etiologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4048229T3 true PL4048229T3 (pl) | 2026-04-20 |
Family
ID=69743769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20801016.5T PL4048229T3 (pl) | 2019-10-24 | 2020-10-22 | Kompozycja farmaceutyczna do zastosowania w leczeniu zapalenia pęcherza moczowego o różnej etiologii |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240075054A1 (pl) |
| EP (1) | EP4048229B1 (pl) |
| CA (1) | CA3153498A1 (pl) |
| DK (1) | DK4048229T3 (pl) |
| ES (1) | ES3062926T3 (pl) |
| FI (1) | FI4048229T3 (pl) |
| HR (1) | HRP20260259T1 (pl) |
| IT (1) | IT201900019762A1 (pl) |
| LT (1) | LT4048229T (pl) |
| PL (1) | PL4048229T3 (pl) |
| PT (1) | PT4048229T (pl) |
| WO (1) | WO2021079303A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12383700B2 (en) | 2019-06-13 | 2025-08-12 | Hollister Incorporated | Reusable urinary catheter products |
| EP4628107A3 (en) | 2019-06-25 | 2025-12-17 | Hollister Incorporated | Reusable urinary catheter products |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2553099B1 (fr) | 1983-10-11 | 1989-09-08 | Fidia Spa | Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1263393B (it) | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare |
| IN181358B (pl) * | 1995-02-14 | 1998-05-30 | Bioniche Inc | |
| IT1296689B1 (it) * | 1997-11-06 | 1999-07-14 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario |
| EP3406244B1 (en) * | 2009-04-15 | 2023-06-07 | BMG Pharma S.p.A. | Compositions comprising zinc gluconate and taurine for mucosal or dermal disorders |
| IT1402384B1 (it) | 2010-09-09 | 2013-09-04 | Fidia Farmaceutici | Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium |
| IT1402385B1 (it) | 2010-09-09 | 2013-09-04 | Fidia Farmaceutici | Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis |
| US9849086B2 (en) * | 2012-03-19 | 2017-12-26 | Nanologix Research, Inc. | Method and composition for treating cystitis |
| ITMI20131971A1 (it) | 2013-11-26 | 2015-05-27 | Fidia Farmaceutici | Composizioni farmaceutiche ad attività idratante e lubrificante |
| CA2896038C (en) * | 2015-07-03 | 2022-08-09 | Glycobiosciences Inc. | Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof |
| IT201600079633A1 (it) | 2016-07-28 | 2018-01-28 | Fidia Farm Spa | Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico |
| IT201700081449A1 (it) | 2017-07-18 | 2019-01-18 | Fidia Farm Spa | Procedimento di purificazione dell'acido ialuronico |
-
2019
- 2019-10-24 IT IT102019000019762A patent/IT201900019762A1/it unknown
-
2020
- 2020-10-22 PT PT208010165T patent/PT4048229T/pt unknown
- 2020-10-22 LT LTEPPCT/IB2020/059922T patent/LT4048229T/lt unknown
- 2020-10-22 EP EP20801016.5A patent/EP4048229B1/en active Active
- 2020-10-22 CA CA3153498A patent/CA3153498A1/en active Pending
- 2020-10-22 DK DK20801016.5T patent/DK4048229T3/da active
- 2020-10-22 FI FIEP20801016.5T patent/FI4048229T3/fi active
- 2020-10-22 WO PCT/IB2020/059922 patent/WO2021079303A1/en not_active Ceased
- 2020-10-22 US US17/766,872 patent/US20240075054A1/en active Pending
- 2020-10-22 ES ES20801016T patent/ES3062926T3/es active Active
- 2020-10-22 PL PL20801016.5T patent/PL4048229T3/pl unknown
- 2020-10-22 HR HRP20260259TT patent/HRP20260259T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK4048229T3 (da) | 2026-02-16 |
| IT201900019762A1 (it) | 2021-04-24 |
| EP4048229B1 (en) | 2025-12-03 |
| FI4048229T3 (fi) | 2026-02-12 |
| ES3062926T3 (en) | 2026-04-14 |
| WO2021079303A1 (en) | 2021-04-29 |
| CA3153498A1 (en) | 2021-04-29 |
| HRP20260259T1 (hr) | 2026-04-10 |
| EP4048229A1 (en) | 2022-08-31 |
| US20240075054A1 (en) | 2024-03-07 |
| LT4048229T (lt) | 2026-03-10 |
| PT4048229T (pt) | 2026-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3577135T3 (pl) | Kompozycja farmaceutyczna do stosowania do leczenia lub zapobiegania chorobom związanym z c5 | |
| IL272121A (en) | Preparation and methods for the treatment of myopia | |
| SI4101454T1 (sl) | Sestavki za uporabo pri zdravljenju hipertenzije | |
| SMT202100693T1 (it) | Composizione liquida per uso nel trattamento del reflusso gastroesofageo | |
| GB2581876B (en) | Compositions for use in the treatment of endometrial disorder | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| EP3291818A4 (en) | Compositions and methods for delivering therapeutic agents into the colon | |
| LT4048229T (lt) | Farmacinė kompozicija, skirta panaudoti įvairių etiologijų cistito gydymui | |
| HUE063383T2 (hu) | Folyékony készítmény az oro-faringo-laringo-özofageális traktus nyálkahártyájának kezelésében történõ felhasználásra | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL276697A (en) | 3 Beta-(4-methoxybenzyloxy)paragan-5-en-20-one for use in the treatment of cannabinoid-related disorders | |
| LT3548006T (lt) | Kompozicija, skirta žarnyno pakitimams gydyti | |
| IL288307A (en) | Preparations for use in the treatment of insulin deficiency conditions | |
| IL286533A (en) | Compounds for use in the treatment of adcy5-related dyskinesia | |
| GB2569682B (en) | Topical composition for use in the treatment of burns | |
| SI3586832T1 (sl) | Farmacevtski sestavek za zdravljenje zaprtja | |
| HK40074743A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| HK40044464A (en) | R-fadrozole for use in the treatment of aldostonerism | |
| GB201911821D0 (en) | Compounds for use in the treatment of liver disease | |
| GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| HK40005766B (en) | Topical composition for use in the treatment of burns | |
| HK40005766A (en) | Topical composition for use in the treatment of burns | |
| HK40009824A (en) | Pharmaceutical composition for use in the treatment of prostate pathologies | |
| GB201817346D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of diseases | |
| GB201816896D0 (en) | Novel compositions having use in therapy |